Literature DB >> 1854159

Plasmid-encoded fosfomycin resistance.

J E Suárez1, M C Mendoza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1854159      PMCID： PMC245108          DOI： 10.1128/AAC.35.5.791

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  52 in total

1.  Isolation and nucleotide sequencing of an aminocyclitol acetyltransferase gene from Streptomyces rimosus forma paromomycinus.

Authors:  M López-Cabrera; J A Pérez-González; P Heinzel; W Piepersberg; A Jiménez
Journal:  J Bacteriol       Date:  1989-01       Impact factor: 3.490

2.  Molecular relationship among fosfomycin-resistant plasmids and clinical impact of fosfomycin resistance.

Authors:  M C Mendoza; F J Teran; F J Mendez; C Hardisson
Journal:  Microbiologica       Date:  1988-10

3.  Cloning and molecular epidemiology of plasmid-determined fosfomycin resistance.

Authors:  C J Villar; C Hardisson; J E Suárez
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 4.  The Leeuwenhoek lecture, 1987. Towards an understanding of gene switching in Streptomyces, the basis of sporulation and antibiotic production.

Authors:  D A Hopwood
Journal:  Proc R Soc Lond B Biol Sci       Date:  1988-11-22

5.  The relationship between base composition and codon usage in bacterial genes and its use for the simple and reliable identification of protein-coding sequences.

Authors:  M J Bibb; P R Findlay; M W Johnson
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

6.  [Prevalence and dispersion of plasmids conferring fosfomycin resistance in enterobacteria].

Authors:  C Hardisson; C J Villar; J Llaneza; M C Mendoza
Journal:  Pathol Biol (Paris)       Date:  1984-09

7.  Plasmid-mediated resistance to fosfomycin in Staphylococcus epidermidis.

Authors:  J Etienne; G Gerbaud; P Courvalin; J Fleurette
Journal:  FEMS Microbiol Lett       Date:  1989-10-01       Impact factor: 2.742

8.  Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats.

Authors:  S Inouye; T Niizato; I Komiya; Y Yuda; Y Yamada
Journal:  J Pharmacobiodyn       Date:  1982-12

9.  Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

Authors:  V M Figueredo; H C Neu
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

10.  The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.

Authors:  S Gatermann; E Schulz; R Marre
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553
View more
  25 in total

1.  Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.

Authors:  M Shimizu; F Shigeobu; I Miyakozawa; A Nakamura; M Suzuki; S Mizukoshi; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  The Streptomyces-produced antibiotic fosfomycin is a promiscuous substrate for archaeal isopentenyl phosphate kinase.

Authors:  Mark F Mabanglo; Adrian W R Serohijos; C Dale Poulter
Journal:  Biochemistry       Date:  2012-01-11       Impact factor: 3.162

3.  Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy-d-xylulose 5-Phosphate Synthase.

Authors:  Sara Sanders; Ryan J Vierling; David Bartee; Alicia A DeColli; Mackenzie J Harrison; Joseph L Aklinski; Andrew T Koppisch; Caren L Freel Meyers
Journal:  ACS Infect Dis       Date:  2017-06-21       Impact factor: 5.084

Review 4.  Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 5.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

6.  Structural and biochemical insights into the mechanism of fosfomycin phosphorylation by fosfomycin resistance kinase FomA.

Authors:  Svetlana Pakhomova; Sue G Bartlett; Pamela A Doerner; Marcia E Newcomer
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

7.  FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis.

Authors:  M Cao; B A Bernat; Z Wang; R N Armstrong; J D Helmann
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

8.  Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli.

Authors:  S Kobayashi; T Kuzuyama; H Seto
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

9.  In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.

Authors:  F Tessier; C Quentin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

10.  Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Authors:  Alexandro Rodríguez-Rojas; María D Maciá; Alejandro Couce; Cristina Gómez; Alfredo Castañeda-García; Antonio Oliver; Jesús Blázquez
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.